跳至主要内容
临床试验/NL-OMON42014
NL-OMON42014已完成2 期

Mapping of Sentinel lymph node drainage Using SPECT to tailor highly-selective elective nodal irradiation in node-negative neck of patients with head and neck cancer (SUSPECT) - SN-SPECT for tailoring elective nodal irradiation

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Newly diagnosed patients with histopathologic proven primary HNSCC (T1-3N0-2b with maximally 3 involved nodes without extranodal spread) located in the oral cavity, oropharynx, larynx (except T1 glottic), and hypopharynx, not crossing the midline and planned for treatment with (chemo)radiotherapy in curative setting
  • * No chemotherapy or surgery prior to inclusion
  • * No distant metastatic spread
  • * Age * 18 years
  • * WHO performance status 0 or 1
  • * Signed written informed consent

排除标准

  • * Patients with previously radiation treatment in the head and neck region, for any reason.
  • * Patients with previous neck dissection.
  • * Patients with recurrent or second primary tumor in the head and neck region
  • * Patients with head and neck malignancies arising from skin, lip, nose, sinuses, nasopharynx, salivary glands, thyroid gland or esophagus.
  • * Previous history of cancer in the last 5 years (excluding basal cell carcinoma of the skin and in situ SCC of the cervix)
  • * Pregnancy or no active contraception for pre-menopausal women
  • * Known hypersensitivity to iodine or nanocolloid injection
  • * Having any condition (physical, mental, sociological) that interferes with the informed consent procedure and follow-up schedules

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验